OB/GYN Ultrasound-Core Course March 2021
|IMPORTANT BROWSER INFORMATION|
This site will not work on Internet Explorer 8. Please download one of the preferred browsers:
This three-day program provides a more in-depth coverage of ultrasound applications in obstetrics and gynecology. Approximately three-quarters of the program is devoted to obstetrics and the remainder to gynecology.
Practicing clinicians and sonographers will be able to refresh their knowledge in gynecological areas such as the post-menopausal uterus, endometrial disorders, adnexal masses, transvaginal imaging and obstetrics including problem-solving with obstetrical measurements, exposure to Doppler in Ob/Gyn, bioeffects and invasive procedures.
To successfully complete this activity, the required evaluation must be completed no later than Monday, April 26, 2021. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
This course is designed for physicians and sonographers practicing in the areas of obstetrics and gynecology.
After completing this educational activity, learners will be able to:
- Recognize the acoustic representation of normal anatomy of the fetus and the female pelvis.
- Describe the capabilities and limitations of ultrasound in Obstetrics and Gynecology.
- Identify pathologies of the fetus, uterus, and ovaries from ultrasound images.
- Describe basic ultrasound scanning of the non-pregnant female pelvis.
This educational activity has no commercial or in-kind support.
Recording and Photography Strictly Prohibited
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.
This is a virtual conference.
Thomas Jefferson University endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any relevant financial relationships with ACCME defined commercial interest entities within the past 12 months. Any conflict of interests have been resolved prior to this educational activity.
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
The members of the planning committee have no conflict of interest to disclose.
Mani Montazemi, RDMS-Course Director
Jodi S. Markizon, CMP
The presenters for this educational activity have the following to disclose:
Mani Montazemi, RDMS
No conflict of interest to disclose
Leslie Scoutt, MD
Philips Health Care-honoraria for CME
All presenters are required to disclose whether their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: The Thomas Jefferson University designates this educational activity for a maximum of 18.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals: This educational activity is designated for 18.25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Participants may claim .25 credit one time for the completion of the required evaluation.
Daily Credit Breakdown
March 10: 6.0 AMA PRA Category 1 Credits™
March 11: 6.0AMA PRA Category 1 Credits™
March 12: 6.0 AMA PRA Category 1 Credits™
- 18.25 AMA PRA Category 1 Credit™
- 18.25 Attendance